BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6543411)

  • 1. Isolation of the products resulting from the reaction of cis and trans diaminedichloroplatinum [II] with DNA and chromatin on the Dowex 50 W column.
    Oliński R; Walter Z
    Z Naturforsch C Biosci; 1984; 39(11-12):1057-62. PubMed ID: 6543411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of the adducts of platinum complexes and nucleic acid bases on the Dowex 50 W column.
    Oliński R; Walter Z
    Z Naturforsch C Biosci; 1984; 39(11-12):1052-6. PubMed ID: 6543410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the extent of platination and the sites of Pt binding after interaction of cis- and trans-diamminedichloroplatinum(II) with DNA and chromatin.
    Oliński R; Wiaderkiewicz R; Walter Z
    Acta Biochim Pol; 1985; 32(2):119-25. PubMed ID: 4041106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
    Lippert B
    Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of trans-[Pt(NH3)2Cl2] adducts of d(CCTCGAGTCTCC).d(GGAGACTCGAGG).
    Lepre CA; Chassot L; Costello CE; Lippard SJ
    Biochemistry; 1990 Jan; 29(3):811-23. PubMed ID: 2159792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical analysis on the transition state of the anticancer drug trans-[PtCl2(isopropylamine)2] and its cis isomer binding to DNA purine bases.
    Zhou L
    J Phys Chem B; 2009 Feb; 113(7):2110-27. PubMed ID: 19173577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and quantification of adducts formed upon interaction of diamminedichloroplatinum (II) with DNA, by anion-exchange chromatography after enzymatic degradation.
    Fichtinger-Schepman AM; Lohman PH; Reedijk J
    Nucleic Acids Res; 1982 Sep; 10(17):5345-56. PubMed ID: 6216456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.
    Fichtinger-Schepman AM; van der Veer JL; den Hartog JH; Lohman PH; Reedijk J
    Biochemistry; 1985 Jan; 24(3):707-13. PubMed ID: 4039603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).
    Sundquist WI; Lippard SJ; Stollar BD
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8225-9. PubMed ID: 2446320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA topology on an increase in positive writhing number of DNA: conformation changes in the time course of cis-diamminedichloroplatinum(II)-DNA adducts.
    Kobayashi S; Nakamura Y; Maehara T; Hamashima H; Sasatsu M; Asano K; Ohishi Y; Tanaka A
    Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1053-60. PubMed ID: 11558585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNase I footprinting of cis- or trans-diamminedichloroplatinum(II)-modified DNA.
    Schwartz A; Leng M
    J Mol Biol; 1994 Mar; 236(4):969-74. PubMed ID: 8120904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical reactivity of monofunctional platinum-DNA adducts.
    Butour JL; Johnson NP
    Biochemistry; 1986 Aug; 25(16):4534-9. PubMed ID: 3768295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione.
    Eastman A; Barry MA
    Biochemistry; 1987 Jun; 26(12):3303-7. PubMed ID: 3651385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of cis- and trans-diamminedichloroplatinum(II) to deoxyribonucleic acid exposes nucleosides as measured immunochemically with anti-nucleoside antibodies.
    Sundquist WI; Lippard SJ; Stollar BD
    Biochemistry; 1986 Apr; 25(7):1520-4. PubMed ID: 3707890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical versatility of transplatin monofunctional adducts within multiple site-specifically platinated DNA.
    Bernal-Méndez E; Boudvillain M; González-Vilchez F; Leng M
    Biochemistry; 1997 Jun; 36(24):7281-7. PubMed ID: 9200676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of bifunctional adducts produced in DNA by trans-diamminedichloroplatinum(II).
    Eastman A; Jennerwein MM; Nagel DL
    Chem Biol Interact; 1988; 67(1-2):71-80. PubMed ID: 3262435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophoretic analysis of DNA modifications induced by cis- and trans-diamminedichloroplatinum (II) during heat-denaturation of conformation isomers of pBR322 DNA.
    Rauko P; Hrubisko M; Hanusovská E
    Neoplasma; 1990; 37(2):131-8. PubMed ID: 2342628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of combined treatment with platinum complexes and ionizing radiation on DNA in vitro.
    Vrána O; Brabec V
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Dec; 50(6):995-1007. PubMed ID: 3491805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication.
    Heiger-Bernays WJ; Essigmann JM; Lippard SJ
    Biochemistry; 1990 Sep; 29(36):8461-6. PubMed ID: 2174701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum (II) and analysis of adduct-related DNA-unwinding.
    Fichtinger-Schepman AM; Baan RA; Luiten-Schuite A; van Dijk M; Lohman PH
    Chem Biol Interact; 1985 Nov; 55(3):275-88. PubMed ID: 4075437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.